Advertise with us
Clinical Group

Global Journal of Cancer Therapy 


    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Type of LicenseCreative Commons
    • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
      • Permanent article identifierDOI (Digital Object Identifier)
    • Show +
    • NamePeertechz Publications Inc.,
      10880 Wilshire Blvd., Los Angeles, California, 90024, USA
    • Show +


    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Executive Editors

    Tsuyoshi Shirakawa
    Office Doctor
    Department of Medicine
    Kyushu University

    After I graduated from Kyushu University Graduate School of Medical Sciences in 2004, I started junior residency at Kyushu Medical Center and Kyushu University hospital from 2004 to 2006. Next, I worked as a senior resident at Kyushu Cancer Center hospital in 2006. Then, I researched about cancer stem cells at Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science.
    I got Diplomate, Subspeciality Board of Medical Oncology in 2012, and worked as a chief resident National Cancer Center Hospital, Tokyo. At National Cancer Center Hospital, I researched about esophageal cancer chemotherapy mainly.
    Then, I joined and worked at the department of Gastrointestinal and Clinical Oncology Division of Kyushu Cancer Center Hospital from 2013 to 2015. From 2015 to 2017, I was a head of Oncology division of Miyazaki Prefectural Miyazaki Hospital, and a main and leading member of Kyushu Medical Oncology Group and Kyushu-Yamaguchi Total Oncology Group, respectively. Now in 2018, I work in Karatsu Higashi-matsuura Medical Association Center as a doctor of internal medicine.

    Research Interest:

    Medical Oncology (Mainly Gastrointestinal Cancer), Cancer stem cell (Basic research), Palliative medicine, General Medicine, Gastroenterology, Clinical study, Multi-disciplinary coordination and multi-disciplinary study.


    Original articles
    Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation. Rinsho Ketsueki. 2006 Oct;47(10):1372-6.

    A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy. Cancer Chemother Pharmacol (2014) 74:1207-15, DOI 10.1007/s00280-014-2597-3.

    Improvement in the awareness of palliative care nursing using STAS-J in an acute care hospital. J Palliat Care Med 2015, 5:3

    Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients. Anti-Cancer Drugs. 2016 Oct; 27(9): 891-8.

    Analysis of a questionnaire survey regarding current conditions against exposure to anticancer drugs and reports of cancer chemotherapy at outpatient departments in Japan. Pharmacology & Pharmacy, 2017, 8, 140-152.

    Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp Cell Res. 2012 Sep 10;318(15):1799-807.

    Human STEAP3 maintains tumor growth under hypoferric condition. Exp Cell Res. 2011 Nov 1;317(18):2582-91.

    Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases. Anticancer research 2014, 34: 215-220.

    Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan. Anticancer research 2014, 34: 2035-2040.

    Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan.
    Anti-Cancer Drugs 2016, 27(5): 457-63.

    Efficacy and Safety of TAS-102 in clinical practice of salvage chemotherapy for metastatic colorectal cancer. Anticancer Research 2016 Apr; 36(4): 1959-66.

    Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours. Cancer Chemother Pharmacol, 2016 Jul 15 DOI 10.1007/s00280-016-3106-7.

    Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2017 May 11 DOI: 10.1007/s10120-017-0725-6.

    Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer Chemotherapy Pharmacology, 2017 Jun 26. DOI 10.1007/s00280-017-3371-0.

    Irinotecan mnotherapy as third-line or later treatment in advanved gastric cancer. Gastric Cancer, 21(3), 464-472 DOI 10.1007/s10120-017-0759-9.

    Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer. Anticancer Drugs, 2017 Sep 12 DOI 10.1097/CAD.0000000000000562.

    Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer. Anticancer Res. 2017 Nov;37(11):6459-6468.

    Corresponding author
    Successful chemoradiotherapy for neuroendocrine tumor grade 3 arising from the mandibular gingiva: a case report and literature review. Open Journal of clinical & medical case report, Volume 2 (2016) Issue 5: 1089.

    Case reports
    A complete response to second-line chemotherapy with sunitinib of a gastrointestinal stromal tumor: A case report. Molecular and Clinical Oncology 2017 Jul; 7(1): 93-97.

    Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report. J Med Case Rep. 2012, 6:315.

    Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review. Int canc conf J. 2012 Oct DOI10.1007/s13691-012-0060-z.

    Successful Chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary artery Case Rep Oncol 2014;7:484-490.

    Successful multimodal therapy for undifferentiated carcinoma with neuroendocrine differentiation in the clival region. Int canc conf J. 2014 July DOI 10.1007/s13961-014-0179-1.

    Anti-HER2 combination chemotherapy for advanced gastric cancer associated with the Peutz-Jeghers syndrome: a case report and literature review. Int canc conf J. 2013 Nov DOI 10.1007/s13961-013-0139-1.

    Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis. Molecular and Clinical Oncology 5: 579-582, 2016.

    More Info.

    Editorial Board Join as Editor

    Rosaria Benedetti
    Second University of Naples Italy

    Rsearch Interest: Molecular Biology, Cell Biology, Cancer Research

    More Info.
    Grivas Nikolaos
    Associate Member of EAU
    University of Ioannina

    Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

    More Info.
    Dhruv Kumar
    Pharmacology, Toxicologyand Theraputics
    The University of Kansas Medical Center,

    Research Interest: Biological Skills. Plasmid Amplification And Purification, Transformation, Transfection, Transduction,Protein Isolation, Western Blot, Cell Viability And Apoptosis Assay, FluorescenceMicroscopy, Flow Cytometry, Real-Time PCR, Tissue Processing, Tissue Culture,Immunohistochemistry, XF Flux Analyzer And Mice Handling.Biophysical Skills. A Complete Understanding Of Atomic Force Microscopy To Study IntrinsicallyUnstructured Proteins Related To Neurodegenerative Disease (Parkinson’s AndAlzheimer’s Disease).Bioinformatics Skills. Software: Python, Autodock, NCBI Software Suits, Rasmol, Clustal-X And W, VMD,Phylip, Tree View,Pymol, Arguslab And Genscan Etc. Biological Databases: Genbank, EMBL, DDBJ, Pfam, PDB, Swiss Prot, Trembl Etc. Muser Friendly With Proteomics Server Expasy.Information Technology Skills

    More Info.
    Maria Saridi
    Director Nursing
    University of Peloponnese
    Research Interest: Nursing Care Delivery Systems, Community Nursing, Hospital Information Systems, Surgical Nursing, Health Education, Prevention, Nosocomial Infections, Occupational Health, Community Healthcare
    More Info.
    Manzoor Ahmad Rather
    Division of Medicinal Chemistry
    Indian Institute of Integrative Medicine

    Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

    More Info.
    Abdel-Moneim Osman
    Department of Medicine
    King Abdel-Aziz University
    Saudi Arabia
    Research Interest: Cancer Research.Pharmacology, Cell Cycle Effect, Drug-Drug Intertaction, Chemoprotection, Potentiation olf Cytotoxic Drugs
    More Info.
    Qinong Ye
    Department of Medical Molecular Biology/Oncology
    Beijing Institute of Biotechnology

    Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response

    More Info.
    Edgar Selzer
    Landesklinikum Wiener Neustadt
    Medical University Vienna

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research

    More Info.
    Tsuyoshi Shirakawa
    Department of Oncology
    Miyazaki University Hospital

    Research Interest: Medical Oncology (Mainly Gastrointestinal Cancer), Cancer Stem Cell, Palliative Medicine,Multi-Disciplinary Coordination And Multi-Disciplinary Study

    More Info.
    Esteban Orenes-Pinero
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia

    Research Interest: Current Professional Activity: Fibrilación Auricular, Miocardiopatía Hipertrófica, Micrornas,Remodelado Cardíaco

    More Info.
    Letizia Polito
    Assistant Professor
    Department of Experimental
    University of Bologna

    Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.

    More Info.
    Kailash Chadha
    Department of Molecular and Cellular Biology
    Roswell Park Cancer Institute

    Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.

    More Info.
    Xingding Zhang
    Assistant Professor
    Diagnosis and Nanomedicine Engineering Technology Center

    Research Interest: Autophagy and Apoptosis

    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan

    Research Interest: Clinical Oncology

    More Info.
    Stefania Staibano
    Department of Pathology
    University of Naples Federico II

    Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology

    More Info.
    View more

    Video Endoscopic Inguinal Lymphadenectomy: Refi ning surgical technique after ten years experience

    Published On: December 30, 2017 | Pages: 034 - 037

    Author(s): Marcos Tobias-Machado, Pericles Rios Auad*, Victor Corona, Igor Silva, Oseas de Castro Neves, Eliney Ferreira Faria, Pablo Matos, Alexandre Cesar Santos, Roberto Machado, Aurus Dourado and Hamilton de Campos Zampolli
    Abstract View Full Article View DOI: 10.17352/gjct.000021

    Role of tumor heterogeneity in drug resistance

    Published On: July 20, 2017 | Pages: 032 - 033

    Author(s): Dhruv Kumar*
    Abstract View Full Article View DOI: 10.17352/gjct.000020

    MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer

    Published On: May 26, 2017 | Pages: 030 - 031

    Author(s): Julius Strauss*
    Abstract View Full Article View DOI: 10.17352/gjct.000019

    Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor

    Published On: April 15, 2017 | Pages: 026 - 029

    Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
    Abstract View Full Article View DOI: 10.17352/gjct.000018

    The Promise of Disease Management in Greece

    Published On: March 30, 2017 | Pages: 018 - 025

    Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
    Abstract View Full Article View DOI: 10.17352/gjct.000017

    Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report

    Published On: March 20, 2017 | Pages: 015 - 017

    Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
    Abstract View Full Article View DOI: 10.17352/gjct.000016

    The Role of Decavanadate in Anti- Tumour Activity

    Published On: March 11, 2017 | Pages: 012 - 014

    Author(s): M Aureliano*
    Abstract View Full Article View DOI: 10.17352/gjct.000015

    Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language

    Published On: March 07, 2017 | Pages: 008 - 011

    Author(s): Daniela Russo#, Francesco Merolla#, Gennaro Ilardi*, Silvia Varricchio, Danila Caroppo, Virginia Napolitano, Massimo Mascolo and Stefania Staibano
    Abstract View Full Article View DOI: 10.17352/gjct.000014

    Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients

    Published On: February 28, 2017 | Pages: 004 - 007

    Author(s): Mostafa El Haddad*
    Abstract View Full Article View DOI: 10.17352/gjct.000013

    Primary Spindle Cell Rhabdomyosarcoma of Prostate: A Case Report with Review of Literature

    Published On: February 10, 2017 | Pages: 001 - 003

    Author(s): Ram Nawal Rao*, Sanjay Kannaujia and Paramita Paul
    Abstract View Full Article View DOI: 10.17352/gjct.000012

    Google Ads

    Peertechz @Social

    Peertechz Tweets

    Case Reports

    Pinterest on GJCT